CAR T cell therapy is a type of immunotherapy used to treat lymphoma, multiple myeloma and some forms of leukemia. The treatment modifies T cells so that they can better recognize and attack cancer.
To learn what to expect if you need CAR T cell therapy, we spoke with lymphoma and myeloma specialist Sairah Ahmed, M.D.
Your care team will determine if you’re eligible for CAR T cell therapy
Before you can consider...
From unlocking the secrets of the tumor microenvironment to advancing new therapies to FDA approval, MD Anderson researchers are driven by...
Jeremiah Bergeron pays close attention to detail. As a nurse caring for hospital patients receiving CAR T cell therapy, Bergeron monitors...
Since MD Anderson’s first CAR T cell therapy clinical trial launched in 2015, we’ve cared for hundreds of patients undergoing CAR T cell therapy. Over the years, we’ve gained valuable insight into this game-changing treatment that trains a patient’s immune system to find and kill cancer cells.
With CAR T cell therapy, T cells that defend the body against disease are extracted from a cancer patient’s blood. The cells are then changed...
Until she came to MD Anderson, 82-year-old Myrna Youmans had never heard the words “smoldering myeloma.” So, she didn’t know that they described...
When I was diagnosed with multiple myeloma at age 63, it actually didn’t bother me. I felt like whatever this was, God had a plan charted...
As a senior medical laboratory scientist at MD Anderson, I work behind the scenes to analyze patients’ lab work. My findings play a crucial...
Many patients’ goal for cancer treatment is cure. But what if there isn’t a known cure for your diagnosis? That’s the case for patients with...
Since they were first introduced more than 60 years ago, stem cell transplants have cured or extended the lives of millions diagnosed with...
Blood cancers like lymphoma and multiple myeloma begin in blood-forming tissue, such as bone marrow or in cells of the...